These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 7932411)
21. Clinical implications of the presence of anti-Ro (SSA) antibodies in patients with rheumatoid arthritis. Skopouli FN; Andonopoulos AP; Moutsopoulos HM J Autoimmun; 1988 Aug; 1(4):381-8. PubMed ID: 3266995 [TBL] [Abstract][Full Text] [Related]
22. Anti-p53 antibodies are rarely detected in serum of patients with rheumatoid arthritis and Sjögren's syndrome. Mariette X; Sibilia J; Delaforge C; Bengoufa D; Brouet JC; Soussi T J Rheumatol; 1999 Aug; 26(8):1672-5. PubMed ID: 10451060 [TBL] [Abstract][Full Text] [Related]
23. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease. Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526 [TBL] [Abstract][Full Text] [Related]
24. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508 [TBL] [Abstract][Full Text] [Related]
25. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846 [TBL] [Abstract][Full Text] [Related]
28. Clinical and serological heterogeneity in patients with anticentromere antibodies. Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324 [TBL] [Abstract][Full Text] [Related]
29. Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. Cavazzana I; Franceschini F; Quinzanini M; Manera C; Del Papa N; Maglione W; Comina D; Radice A; Sinico RA; Cattaneo R Clin Exp Rheumatol; 2006; 24(1):59-64. PubMed ID: 16539820 [TBL] [Abstract][Full Text] [Related]
30. Spectrum and clinical significance of autoantibodies against transfer RNA. Ohosone Y; Ishida M; Takahashi Y; Matsumura M; Hirakata M; Kawahara Y; Nishikawa T; Mimori T Arthritis Rheum; 1998 Sep; 41(9):1625-31. PubMed ID: 9751095 [TBL] [Abstract][Full Text] [Related]
31. [Dynamics of circulating anti-tissue antibodies and titer of rheumatoid factor in rheumatoid polyarthritis under the effect of immunosuppressive drugs, antimalarials and gold salts]. Andreev T; Kozhukharova M; Pilosof T Vutr Boles; 1972; 11(3):125-8. PubMed ID: 4547886 [No Abstract] [Full Text] [Related]
32. Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjögren's syndrome. Yavuz S; Toker E; Bicakcigil M; Mumcu G; Cakir S J Rheumatol; 2006 Jul; 33(7):1289-92. PubMed ID: 16821267 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [TBL] [Abstract][Full Text] [Related]
34. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258 [TBL] [Abstract][Full Text] [Related]
35. [Keratoconjunctivitis sicca in rheumatoid arthritis: correlation with the autoantibody pattern]. Altomonte L; Zoli A; Galossi A; Mirone L; Scuderi F; Magarò M Ann Ital Med Int; 1995; 10(2):103-6. PubMed ID: 7619648 [TBL] [Abstract][Full Text] [Related]
36. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?]. Meyer O Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426 [TBL] [Abstract][Full Text] [Related]
37. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940 [TBL] [Abstract][Full Text] [Related]
38. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D; Gülmez D; Hasçelik G Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440 [TBL] [Abstract][Full Text] [Related]
40. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Liu X; Jia R; Zhao J; Li Z J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]